Report Detail

Request for Sample of this report

Medical Devices & Consumables Global and United States Hemostat Powder and Hemostatic Agents Market Report & Forecast 2022-2028

  • RnM4420649
    • |
  • 06 April, 2022
    • |
  • Global
    • |
  • 116 Pages
    • |
  • QYResearch
    • |
  • Medical Devices & Consumables

Summary:

When blood vessel walls are disrupted during surgeries, there are occurrences of blood loss, which needs to get coagulated. This process of blood clot formation at the site of injury is known as hemostasis. Hence, hemostats offer temporary blockage by forming blood clot to control bleeding.
Market Analysis and Insights: Global and United States Hemostat Powder and Hemostatic Agents Market
This report focuses on global and United States Hemostat Powder and Hemostatic Agents market, also covers the segmentation data of other regions in regional level and county level.
Due to the COVID-19 pandemic, the global Hemostat Powder and Hemostatic Agents market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, by Type, Microfibrillar Collagen accounting for % of the Hemostat Powder and Hemostatic Agents global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While by Application, Minimally Invasive Surgery was the leading segment, accounting for over percent market share in 2021, and altered to an % CAGR throughout this forecast period.
In United States the Hemostat Powder and Hemostatic Agents market size is expected to grow from US$ million in 2021 to US$ million by 2028, at a CAGR of % during the forecast period.
Global Hemostat Powder and Hemostatic Agents Scope and Market Size
Hemostat Powder and Hemostatic Agents market is segmented by region (country), players, by Type and by Application. Players, stakeholders, and other participants in the global Hemostat Powder and Hemostatic Agents market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application for the period 2017-2028.
For United States market, this report focuses on the Hemostat Powder and Hemostatic Agents market size by players, by Type and by Application, for the period 2017-2028. The key players include the global and local players, which play important roles in United States.
Segment by Type, the Hemostat Powder and Hemostatic Agents market is segmented into
Microfibrillar Collagen
Chitosan
Segment by Application, the Hemostat Powder and Hemostatic Agents market is segmented into
Minimally Invasive Surgery
Ordinary Surgery
Other
Regional and Country-level Analysis
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Competitive Landscape and Hemostat Powder and Hemostatic Agents Market Share Analysis
Hemostat Powder and Hemostatic Agents market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2017-2022. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2017-2022. Details included are company description, major business, company total revenue and the sales, revenue generated in Hemostat Powder and Hemostatic Agents business, the date to enter into the Hemostat Powder and Hemostatic Agents market, Hemostat Powder and Hemostatic Agents product introduction, recent developments, etc.
The major vendors covered:
J&J
Baxter
BD
B Braun
Gelita
Integra Life Sciences
Advance Medical Solution
Pfizer
CSL Behring
CryoLife
Zimmer Biomet
Ferrosan Medical Devices
Medtronic
Smith & Nephew
Z-Medica
Cohera Medical
Marine Polymer
Equimedical


Table of Contents

    1 Study Coverage

    • 1.1 Hemostat Powder and Hemostatic Agents Product Introduction
    • 1.2 Global Hemostat Powder and Hemostatic Agents Outlook 2017 VS 2022 VS 2028
      • 1.2.1 Global Hemostat Powder and Hemostatic Agents Sales in US$ Million for the Year 2017-2028
      • 1.2.2 Global Hemostat Powder and Hemostatic Agents Sales in Volume for the Year 2017-2028
    • 1.3 United States Hemostat Powder and Hemostatic Agents Outlook 2017 VS 2022 VS 2028
      • 1.3.1 United States Hemostat Powder and Hemostatic Agents Sales in US$ Million for the Year 2017-2028
      • 1.3.2 United States Hemostat Powder and Hemostatic Agents Sales in Volume for the Year 2017-2028
    • 1.4 Hemostat Powder and Hemostatic Agents Market Size, United States VS Global, 2017 VS 2022 VS 2028
      • 1.4.1 The Market Share of United States Hemostat Powder and Hemostatic Agents in Global, 2017 VS 2022 VS 2028
      • 1.4.2 The Growth Rate of Hemostat Powder and Hemostatic Agents Market Size, United States VS Global, 2017 VS 2022 VS 2028
    • 1.5 Hemostat Powder and Hemostatic Agents Market Dynamics
      • 1.5.1 Hemostat Powder and Hemostatic Agents Industry Trends
      • 1.5.2 Hemostat Powder and Hemostatic Agents Market Drivers
      • 1.5.3 Hemostat Powder and Hemostatic Agents Market Challenges
      • 1.5.4 Hemostat Powder and Hemostatic Agents Market Restraints
    • 1.6 Study Objectives
    • 1.7 Years Considered

    2 Market by Type

    • 2.1 Hemostat Powder and Hemostatic Agents Market Segment by Type
      • 2.1.1 Microfibrillar Collagen
      • 2.1.2 Chitosan
    • 2.2 Global Hemostat Powder and Hemostatic Agents Market Size by Type
      • 2.2.1 Global Hemostat Powder and Hemostatic Agents Sales in Value, by Type (2017, 2022 & 2028)
      • 2.2.2 Global Hemostat Powder and Hemostatic Agents Sales in Volume, by Type (2017, 2022 & 2028)
      • 2.2.3 Global Hemostat Powder and Hemostatic Agents Average Selling Price (ASP) by Type (2017, 2022 & 2028)
    • 2.3 United States Hemostat Powder and Hemostatic Agents Market Size by Type
      • 2.3.1 United States Hemostat Powder and Hemostatic Agents Sales in Value, by Type (2017, 2022 & 2028)
      • 2.3.2 United States Hemostat Powder and Hemostatic Agents Sales in Volume, by Type (2017, 2022 & 2028)
      • 2.3.3 United States Hemostat Powder and Hemostatic Agents Average Selling Price (ASP) by Type (2017, 2022 & 2028)

    3 Market by Application

    • 3.1 Hemostat Powder and Hemostatic Agents Market Segment by Application
      • 3.1.1 Minimally Invasive Surgery
      • 3.1.2 Ordinary Surgery
      • 3.1.3 Other
    • 3.2 Global Hemostat Powder and Hemostatic Agents Market Size by Application
      • 3.2.1 Global Hemostat Powder and Hemostatic Agents Sales in Value, by Application (2017, 2022 & 2028)
      • 3.2.2 Global Hemostat Powder and Hemostatic Agents Sales in Volume, by Application (2017, 2022 & 2028)
      • 3.3.3 Global Hemostat Powder and Hemostatic Agents Average Selling Price (ASP) by Application (2017, 2022 & 2028)
    • 3.3 United States Hemostat Powder and Hemostatic Agents Market Size by Application
      • 3.3.1 United States Hemostat Powder and Hemostatic Agents Sales in Value, by Application (2017, 2022 & 2028)
      • 3.3.2 United States Hemostat Powder and Hemostatic Agents Sales in Volume, by Application (2017, 2022 & 2028)
      • 3.3.3 United States Hemostat Powder and Hemostatic Agents Average Selling Price (ASP) by Application (2017, 2022 & 2028)

    4 Global Hemostat Powder and Hemostatic Agents Competitor Landscape by Company

    • 4.1 Global Hemostat Powder and Hemostatic Agents Market Size by Company
      • 4.1.1 Top Global Hemostat Powder and Hemostatic Agents Manufacturers Ranked by Revenue (2021)
      • 4.1.2 Global Hemostat Powder and Hemostatic Agents Revenue by Manufacturer (2017-2022)
      • 4.1.3 Global Hemostat Powder and Hemostatic Agents Sales by Manufacturer (2017-2022)
      • 4.1.4 Global Hemostat Powder and Hemostatic Agents Price by Manufacturer (2017-2022)
    • 4.2 Global Hemostat Powder and Hemostatic Agents Concentration Ratio (CR)
      • 4.2.1 Hemostat Powder and Hemostatic Agents Market Concentration Ratio (CR) (2017-2022)
      • 4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Hemostat Powder and Hemostatic Agents in 2021
      • 4.2.3 Global Hemostat Powder and Hemostatic Agents Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 4.3 Global Hemostat Powder and Hemostatic Agents Manufacturing Base Distribution, Product Type
      • 4.3.1 Global Hemostat Powder and Hemostatic Agents Manufacturers, Headquarters and Distribution of Producing Region
      • 4.3.2 Manufacturers Hemostat Powder and Hemostatic Agents Product Type
      • 4.3.3 Date of International Manufacturers Enter into Hemostat Powder and Hemostatic Agents Market
    • 4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
    • 4.5 United States Hemostat Powder and Hemostatic Agents Market Size by Company
      • 4.5.1 Top Hemostat Powder and Hemostatic Agents Players in United States, Ranked by Revenue (2021)
      • 4.5.2 United States Hemostat Powder and Hemostatic Agents Revenue by Players (2020, 2021 & 2022)
      • 4.5.3 United States Hemostat Powder and Hemostatic Agents Sales by Players (2020, 2021 & 2022)

    5 Global Hemostat Powder and Hemostatic Agents Market Size by Region

    • 5.1 Global Hemostat Powder and Hemostatic Agents Market Size by Region: 2017 VS 2022 VS 2028
    • 5.2 Global Hemostat Powder and Hemostatic Agents Market Size in Volume by Region (2017-2028)
      • 5.2.1 Global Hemostat Powder and Hemostatic Agents Sales in Volume by Region: 2017-2022
      • 5.2.2 Global Hemostat Powder and Hemostatic Agents Sales in Volume Forecast by Region (2023-2028)
    • 5.3 Global Hemostat Powder and Hemostatic Agents Market Size in Value by Region (2017-2028)
      • 5.3.1 Global Hemostat Powder and Hemostatic Agents Sales in Value by Region: 2017-2022
      • 5.3.2 Global Hemostat Powder and Hemostatic Agents Sales in Value by Region: 2023-2028

    6 Segment in Region Level & Country Level

    • 6.1 North America
      • 6.1.1 North America Hemostat Powder and Hemostatic Agents Market Size YoY Growth 2017-2028
      • 6.1.2 North America Hemostat Powder and Hemostatic Agents Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.1.3 United States
      • 6.1.4 Canada
    • 6.2 Asia-Pacific
      • 6.2.1 Asia-Pacific Hemostat Powder and Hemostatic Agents Market Size YoY Growth 2017-2028
      • 6.2.2 Asia-Pacific Hemostat Powder and Hemostatic Agents Market Facts & Figures by Region (2017, 2022 & 2028)
      • 6.2.3 China
      • 6.2.4 Japan
      • 6.2.5 South Korea
      • 6.2.6 India
      • 6.2.7 Australia
      • 6.2.8 China Taiwan
      • 6.2.9 Indonesia
      • 6.2.10 Thailand
      • 6.2.11 Malaysia
    • 6.3 Europe
      • 6.3.1 Europe Hemostat Powder and Hemostatic Agents Market Size YoY Growth 2017-2028
      • 6.3.2 Europe Hemostat Powder and Hemostatic Agents Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.3.3 Germany
      • 6.3.4 France
      • 6.3.5 U.K.
      • 6.3.6 Italy
      • 6.3.7 Russia
    • 6.4 Latin America
      • 6.4.1 Latin America Hemostat Powder and Hemostatic Agents Market Size YoY Growth 2017-2028
      • 6.4.2 Latin America Hemostat Powder and Hemostatic Agents Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.4.3 Mexico
      • 6.4.4 Brazil
      • 6.4.5 Argentina
    • 6.5 Middle East and Africa
      • 6.5.1 Middle East and Africa Hemostat Powder and Hemostatic Agents Market Size YoY Growth 2017-2028
      • 6.5.2 Middle East and Africa Hemostat Powder and Hemostatic Agents Market Facts & Figures by Country (2017, 2022 & 2028)
      • 6.5.3 Turkey
      • 6.5.4 Saudi Arabia
      • 6.5.5 UAE

    7 Company Profiles

    • 7.1 J&J
      • 7.1.1 J&J Corporation Information
      • 7.1.2 J&J Description and Business Overview
      • 7.1.3 J&J Hemostat Powder and Hemostatic Agents Sales, Revenue and Gross Margin (2017-2022)
      • 7.1.4 J&J Hemostat Powder and Hemostatic Agents Products Offered
      • 7.1.5 J&J Recent Development
    • 7.2 Baxter
      • 7.2.1 Baxter Corporation Information
      • 7.2.2 Baxter Description and Business Overview
      • 7.2.3 Baxter Hemostat Powder and Hemostatic Agents Sales, Revenue and Gross Margin (2017-2022)
      • 7.2.4 Baxter Hemostat Powder and Hemostatic Agents Products Offered
      • 7.2.5 Baxter Recent Development
    • 7.3 BD
      • 7.3.1 BD Corporation Information
      • 7.3.2 BD Description and Business Overview
      • 7.3.3 BD Hemostat Powder and Hemostatic Agents Sales, Revenue and Gross Margin (2017-2022)
      • 7.3.4 BD Hemostat Powder and Hemostatic Agents Products Offered
      • 7.3.5 BD Recent Development
    • 7.4 B Braun
      • 7.4.1 B Braun Corporation Information
      • 7.4.2 B Braun Description and Business Overview
      • 7.4.3 B Braun Hemostat Powder and Hemostatic Agents Sales, Revenue and Gross Margin (2017-2022)
      • 7.4.4 B Braun Hemostat Powder and Hemostatic Agents Products Offered
      • 7.4.5 B Braun Recent Development
    • 7.5 Gelita
      • 7.5.1 Gelita Corporation Information
      • 7.5.2 Gelita Description and Business Overview
      • 7.5.3 Gelita Hemostat Powder and Hemostatic Agents Sales, Revenue and Gross Margin (2017-2022)
      • 7.5.4 Gelita Hemostat Powder and Hemostatic Agents Products Offered
      • 7.5.5 Gelita Recent Development
    • 7.6 Integra Life Sciences
      • 7.6.1 Integra Life Sciences Corporation Information
      • 7.6.2 Integra Life Sciences Description and Business Overview
      • 7.6.3 Integra Life Sciences Hemostat Powder and Hemostatic Agents Sales, Revenue and Gross Margin (2017-2022)
      • 7.6.4 Integra Life Sciences Hemostat Powder and Hemostatic Agents Products Offered
      • 7.6.5 Integra Life Sciences Recent Development
    • 7.7 Advance Medical Solution
      • 7.7.1 Advance Medical Solution Corporation Information
      • 7.7.2 Advance Medical Solution Description and Business Overview
      • 7.7.3 Advance Medical Solution Hemostat Powder and Hemostatic Agents Sales, Revenue and Gross Margin (2017-2022)
      • 7.7.4 Advance Medical Solution Hemostat Powder and Hemostatic Agents Products Offered
      • 7.7.5 Advance Medical Solution Recent Development
    • 7.8 Pfizer
      • 7.8.1 Pfizer Corporation Information
      • 7.8.2 Pfizer Description and Business Overview
      • 7.8.3 Pfizer Hemostat Powder and Hemostatic Agents Sales, Revenue and Gross Margin (2017-2022)
      • 7.8.4 Pfizer Hemostat Powder and Hemostatic Agents Products Offered
      • 7.8.5 Pfizer Recent Development
    • 7.9 CSL Behring
      • 7.9.1 CSL Behring Corporation Information
      • 7.9.2 CSL Behring Description and Business Overview
      • 7.9.3 CSL Behring Hemostat Powder and Hemostatic Agents Sales, Revenue and Gross Margin (2017-2022)
      • 7.9.4 CSL Behring Hemostat Powder and Hemostatic Agents Products Offered
      • 7.9.5 CSL Behring Recent Development
    • 7.10 CryoLife
      • 7.10.1 CryoLife Corporation Information
      • 7.10.2 CryoLife Description and Business Overview
      • 7.10.3 CryoLife Hemostat Powder and Hemostatic Agents Sales, Revenue and Gross Margin (2017-2022)
      • 7.10.4 CryoLife Hemostat Powder and Hemostatic Agents Products Offered
      • 7.10.5 CryoLife Recent Development
    • 7.11 Zimmer Biomet
      • 7.11.1 Zimmer Biomet Corporation Information
      • 7.11.2 Zimmer Biomet Description and Business Overview
      • 7.11.3 Zimmer Biomet Hemostat Powder and Hemostatic Agents Sales, Revenue and Gross Margin (2017-2022)
      • 7.11.4 Zimmer Biomet Hemostat Powder and Hemostatic Agents Products Offered
      • 7.11.5 Zimmer Biomet Recent Development
    • 7.12 Ferrosan Medical Devices
      • 7.12.1 Ferrosan Medical Devices Corporation Information
      • 7.12.2 Ferrosan Medical Devices Description and Business Overview
      • 7.12.3 Ferrosan Medical Devices Hemostat Powder and Hemostatic Agents Sales, Revenue and Gross Margin (2017-2022)
      • 7.12.4 Ferrosan Medical Devices Products Offered
      • 7.12.5 Ferrosan Medical Devices Recent Development
    • 7.13 Medtronic
      • 7.13.1 Medtronic Corporation Information
      • 7.13.2 Medtronic Description and Business Overview
      • 7.13.3 Medtronic Hemostat Powder and Hemostatic Agents Sales, Revenue and Gross Margin (2017-2022)
      • 7.13.4 Medtronic Products Offered
      • 7.13.5 Medtronic Recent Development
    • 7.14 Smith & Nephew
      • 7.14.1 Smith & Nephew Corporation Information
      • 7.14.2 Smith & Nephew Description and Business Overview
      • 7.14.3 Smith & Nephew Hemostat Powder and Hemostatic Agents Sales, Revenue and Gross Margin (2017-2022)
      • 7.14.4 Smith & Nephew Products Offered
      • 7.14.5 Smith & Nephew Recent Development
    • 7.15 Z-Medica
      • 7.15.1 Z-Medica Corporation Information
      • 7.15.2 Z-Medica Description and Business Overview
      • 7.15.3 Z-Medica Hemostat Powder and Hemostatic Agents Sales, Revenue and Gross Margin (2017-2022)
      • 7.15.4 Z-Medica Products Offered
      • 7.15.5 Z-Medica Recent Development
    • 7.16 Cohera Medical
      • 7.16.1 Cohera Medical Corporation Information
      • 7.16.2 Cohera Medical Description and Business Overview
      • 7.16.3 Cohera Medical Hemostat Powder and Hemostatic Agents Sales, Revenue and Gross Margin (2017-2022)
      • 7.16.4 Cohera Medical Products Offered
      • 7.16.5 Cohera Medical Recent Development
    • 7.17 Marine Polymer
      • 7.17.1 Marine Polymer Corporation Information
      • 7.17.2 Marine Polymer Description and Business Overview
      • 7.17.3 Marine Polymer Hemostat Powder and Hemostatic Agents Sales, Revenue and Gross Margin (2017-2022)
      • 7.17.4 Marine Polymer Products Offered
      • 7.17.5 Marine Polymer Recent Development
    • 7.18 Equimedical
      • 7.18.1 Equimedical Corporation Information
      • 7.18.2 Equimedical Description and Business Overview
      • 7.18.3 Equimedical Hemostat Powder and Hemostatic Agents Sales, Revenue and Gross Margin (2017-2022)
      • 7.18.4 Equimedical Products Offered
      • 7.18.5 Equimedical Recent Development

    8 Industry Chain and Sales Channels Analysis

    • 8.1 Hemostat Powder and Hemostatic Agents Industry Chain Analysis
    • 8.2 Hemostat Powder and Hemostatic Agents Key Raw Materials
      • 8.2.1 Key Raw Materials
      • 8.2.2 Hemostat Powder and Hemostatic Agents Distributors
    • 8.3 Hemostat Powder and Hemostatic Agents Production Mode & Process
    • 8.4 Hemostat Powder and Hemostatic Agents Sales and Marketing
      • 8.4.1 Hemostat Powder and Hemostatic Agents Sales Channels
      • 8.4.2 Hemostat Powder and Hemostatic Agents Distributors
    • 8.5 Hemostat Powder and Hemostatic Agents Customers

    9 Research Findings and Conclusion

      10 Appendix

      • 10.1 Research Methodology
        • 10.1.1 Methodology/Research Approach
        • 10.1.2 Data Source
      • 10.2 Author Details

      Summary:
      Get latest Market Research Reports on Hemostat Powder and Hemostatic Agents. Industry analysis & Market Report on Hemostat Powder and Hemostatic Agents is a syndicated market report, published as Global and United States Hemostat Powder and Hemostatic Agents Market Report & Forecast 2022-2028. It is complete Research Study and Industry Analysis of Hemostat Powder and Hemostatic Agents market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      		$3,850.00
      		$7,700.00
      		3,068.45
      		6,136.90
      		3,580.50
      		7,161.00
      		588,588.00
      		1,177,176.00
      		321,205.50
      		642,411.00
      Credit card Logo
      Sample Question Discount Download PDF

      Related Reports

      Reason to Buy

      • Trusted By Leaders

        Top executives from leading companies purchase research reports from us. 

      • Shop With Confidence

        We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

      • Customer Centric

        Need assistance related to your research requirements? We are just a phone call or an email away.

      • Personalized Solutions

        Our experienced research specialists are here to help you locate the right reports for your need.

      • Secure Checkout

        Shop without being worried about safety & security of your transactions.
        •

      Request for Sample of this report

      Reports and Markets

      mcafree

      Contact Us

      +1-352-353-0818 (US)

      info@reportsandmarkets.com

      Support

      EMAIL US

      Newsletter

      KEEP UP TO DATE ON ALL THE LATEST REPORTS


      maxmind_logo